Two recent papers published in JAMA have highlighted the potential need for additional regulatory scrutiny for low-risk digital health technologies used by consumers.

In parallel, Lunai's wholly owned subsidiary BioSymetrics Inc. ("BioSymetrics"), published a new technical white paper, Phenoclustering Parkinson's Disease to Uncover New Targets and Biomarkers. The ...

Our DNA is often pictured as a simple spiral, like a piece of rope held taut. But inside cells, it folds into a complex three ...

As artificial intelligence moves rapidly into cars, robots and industrial equipment, with computing power becoming a core ...

Stevanato Group (NYSE:STVN) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript ...

Discover the zodiac-inspired advice for every sign this Wednesday, August 5, with cosmic reflections to guide your mindset, ...

The Vermont Lottery offers several draw games for those willing to make a bet to win big. Those who want to play can enter ...

Imagine a typical breakfast: coffee may appear alongside eggs, toast and butter, while fruit, yogurt and whole grains may ...

Driven Patient Selection and Precision Medicine in Oncology. Validation Studies Aim to Optimize Clinical Trial Patient Selection Criteria. AUSTIN, ...

Spread the love“`html Artificial intelligence is no longer a futuristic concept; it’s here, and it’s rapidly transforming ...